Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Nutr Res ; 33(9): 772-9, 2013 Sep.
Article in English | MEDLINE | ID: mdl-24034577

ABSTRACT

Measurements of enzyme kinetics of renal Na, K-ATPase were used for characterization of ATP- and Na⁺-binding sites in rats that were subjected to 10 days of moderate inflammation that was induced by a single dose of Escherichia coli lipopolysaccharides (LPSs) at a dose of 1 mg kg⁻¹ body weight. We hypothesized that LPSs might initiate a malfunction of renal Na, K-ATPase, which is a key enzyme involved in regulation of sodium homeostasis in the organism. We also investigated the potential effect that fish oil (FO) has in the prevention of Na, K-ATPase alterations by administering FO daily at a dose of 30 mg kg⁻¹. Alone, LPS elevated the level of C-reactive protein by more than 500% and free radicals by 36% in plasma, as indicated by an increased level of malondialdehyde. The Na, K-ATPase was slightly altered in the vicinity of the ATP-binding site as suggested by the 9% increase of the concentration of ATP necessary for half-maximal activation of the enzyme, thus indicating a deteriorated binding of ATP as a consequence of inflammation. Daily supplementation of FO partly attenuated LPS-induced injury, as observed by a significant decrease in the plasma levels of C-reactive protein and free radicals, hence maintaining the activity of renal Na, K-ATPase to the level of healthy control animals. In conclusion, our findings showed that FO prevented an excessive malondialdehyde production in LPS-treated animals and stabilized renal Na, K-ATPase.


Subject(s)
Dietary Supplements , Fatty Acids, Omega-3/administration & dosage , Kidney/drug effects , Lipopolysaccharides/adverse effects , Sodium-Potassium-Exchanging ATPase/metabolism , Animals , Blood Pressure/drug effects , Body Weight/drug effects , C-Reactive Protein/metabolism , Fish Oils/administration & dosage , Heart Rate/drug effects , Inflammation/drug therapy , Kidney/enzymology , Male , Malondialdehyde/blood , Organ Size/drug effects , Rats , Rats, Wistar , Sodium/metabolism
2.
Mol Cell Biochem ; 366(1-2): 41-8, 2012 Jul.
Article in English | MEDLINE | ID: mdl-22438203

ABSTRACT

The study was focused to the influence of higher intake of cholesterol on properties of the renal Na,K-ATPase, a key system in maintaining the homeostasis of sodium in the organism. Feeding for 4 weeks with cholesterol-enriched food for rats afflicted with hereditary hypertriglyceridemia by itself enhanced the activity of Na,K-ATPase, probably as a consequence of higher number of active enzyme molecules as suggested by 32 % increase of V (max) value. This may be hypothesized as a reason for the increased retention of sodium. Three-week-lasting treatment of animals kept on high cholesterol diet with antioxidant SMe1EC2 in a dose of 10 mg kg(-1) day(-1) normalized the function of renal Na,K-ATPase to the level comparable in hypertriglyceridemic rats fed with the standard diet. Therefore, our results suggest that the antioxidant SMe1EC2 in the applied dose seems to be effective in the attenuation of cholesterol-induced retention of sodium. Treatment for 3 weeks with Fenofibrate in a dose of 100 mg kg(-1) day(-1) reversed the function of renal Na,K-ATPase only slightly.


Subject(s)
Antioxidants/pharmacology , Cholesterol, Dietary/adverse effects , Homeostasis/drug effects , Hyperlipoproteinemia Type IV/metabolism , Indoles/pharmacology , Pyridines/pharmacology , Sodium/metabolism , Animals , Antioxidants/therapeutic use , Body Weight , Cholesterol/blood , Glomerular Filtration Rate/drug effects , Hyperlipoproteinemia Type IV/drug therapy , Hyperlipoproteinemia Type IV/physiopathology , Indoles/therapeutic use , Kidney/drug effects , Kidney/metabolism , Kidney/physiopathology , Kinetics , Male , Organ Size , Oxidative Stress , Proteins/metabolism , Pyridines/therapeutic use , Rats , Sodium-Potassium-Exchanging ATPase , Thiobarbituric Acid Reactive Substances/metabolism , Triglycerides/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...